Literature DB >> 10644492

The Salmonella YopJ-homologue AvrA does not possess YopJ-like activity.

K Schesser1, J M Dukuzumuremyi, C Cilio, S Borg, T S Wallis, S Pettersson, E E Galyov.   

Abstract

The YopJ protein of Yersinia pseudotuberculosis inhibits several eukaryotic signalling pathways that are normally activated in cells following their contact with bacteria. Salmonella encodes a protein, AvrA, that is secreted by the typeIII inv/spa secretion system which is clearly homologous to YopJ (56% identical, 87% similarity). Since AvrA and YopJs similarity also encompassed a region of YopJ that had previously been shown to be critical for its biological activity, we were interested whether AvrA and YopJ provoked similar responses in eukaryotic cells. Two different approaches were used to determine whether AvrA possesses YopJ-like activity in modulating cytokine expression or killing macrophages. An avrA strain of Salmonella dublin was constructed and its activity was compared to an isogenic wildtype counterpart in cellular response assays. In a complementary approach, AvrA was expressed in and delivered into eukaryotic cells by a yopJ strain of Yersinia pseudotuberculosis. We show here that AvrA affects neither cytokine expression or plays a role in macrophage killing when expressed by either Salmonella or Yersinia. Additionally, AvrA does not possess SopB/D-like activity in promoting fluid secretion into infected calf ileal loops. These data indicate that Salmonella and Yersinia trigger and/or modulate eukaryotic cell responses by different typeIII-secreted proteins and suggests that despite their close evolutionary relatedness, AvrA and YopJ perform different functions for Salmonella and Yersinia, respectively. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10644492     DOI: 10.1006/mpat.1999.0324

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  19 in total

Review 1.  Molecular pathogenesis of Salmonella enterica serotype typhimurium-induced diarrhea.

Authors:  Shuping Zhang; Robert A Kingsley; Renato L Santos; Helene Andrews-Polymenis; Manuela Raffatellu; Josely Figueiredo; Jairo Nunes; Renee M Tsolis; L Garry Adams; Andreas J Bäumler
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

2.  Bacterial protein AvrA stabilizes intestinal epithelial tight junctions via blockage of the C-Jun N-terminal kinase pathway.

Authors:  Yongguo Zhang; Shaoping Wu; Jun Ma; Yinglin Xia; Xun Ai; Jun Sun
Journal:  Tissue Barriers       Date:  2015-04-03

3.  Salmonella enterica serovar typhimurium-dependent regulation of inducible nitric oxide synthase expression in macrophages by invasins SipB, SipC, and SipD and effector SopE2.

Authors:  B J Cherayil; B A McCormick; J Bosley
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

Review 4.  Type III secretion: a bacterial device for close combat with cells of their eukaryotic host.

Authors:  G R Cornelis
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-05-29       Impact factor: 6.237

5.  Morphologic and cytokine profile characterization of Salmonella enterica serovar typhimurium infection in calves with bovine leukocyte adhesion deficiency.

Authors:  J S Nunes; S D Lawhon; C A Rossetti; S Khare; J F Figueiredo; T Gull; R C Burghardt; A J Bäumler; R M Tsolis; H L Andrews-Polymenis; L G Adams
Journal:  Vet Pathol       Date:  2009-12-31       Impact factor: 2.221

6.  Identification of a host 14-3-3 Protein that Interacts with Xanthomonas effector AvrRxv.

Authors:  Maureen Whalen; Todd Richter; Kseniya Zakhareyvich; Masayasu Yoshikawa; Dana Al-Azzeh; Adeshola Adefioye; Greg Spicer; Laura L Mendoza; Christine Q Morales; Vicki Klassen; Gina Perez-Baron; Carole S Toebe; Ageliki Tzovolous; Emily Gerstman; Erika Evans; Cheryl Thompson; Mary Lopez; Pamela C Ronald
Journal:  Physiol Mol Plant Pathol       Date:  2008-01       Impact factor: 2.747

7.  Variation between pathogenic serovars within Salmonella pathogenicity islands.

Authors:  P Amavisit; D Lightfoot; G F Browning; P F Markham
Journal:  J Bacteriol       Date:  2003-06       Impact factor: 3.490

8.  Modulation of host innate immune response in the bladder by uropathogenic Escherichia coli.

Authors:  Benjamin K Billips; Sarah G Forrestal; Matthew T Rycyk; James R Johnson; David J Klumpp; Anthony J Schaeffer
Journal:  Infect Immun       Date:  2007-08-27       Impact factor: 3.441

9.  Cycle inhibiting factors (CIFs) are a growing family of functional cyclomodulins present in invertebrate and mammal bacterial pathogens.

Authors:  Grégory Jubelin; Carolina Varela Chavez; Frédéric Taieb; Mark J Banfield; Ascel Samba-Louaka; Rika Nobe; Jean-Philippe Nougayrède; Robert Zumbihl; Alain Givaudan; Jean-Michel Escoubas; Eric Oswald
Journal:  PLoS One       Date:  2009-03-24       Impact factor: 3.240

10.  Selective inhibition of type III secretion activated signaling by the Salmonella effector AvrA.

Authors:  Fangyong Du; Jorge E Galán
Journal:  PLoS Pathog       Date:  2009-09-25       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.